• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oncothyreon Inc

+ Add to Watchlist

3O6:GR

1.518 EUR 0.039 2.50%

As of 02:09:21 ET on 09/17/2014.

Snapshot for Oncothyreon Inc (3O6)

Open: 1.521 Day's Range: 1.518 - 1.522 Volume: 0
Previous Close: 1.557 52wk Range: 1.210 - 2.772 1-Yr Rtn: +14.83%

Stock Chart for 3O6

No chart data available.
  • 3O6:GR 1.521
  • 1D
  • 1M
  • 1Y
1.557
Interactive 3O6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3O6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4750
Est. PEG Ratio -
Market Cap (M EUR) 107.49
Shares Outstanding (M) 70.81
30 Day Average Volume 150
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3O6

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3O6

Oncothyreon, Inc. develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Oncothyreon delivers its services to customers throughout the United States.

Robert L KirkmanPresident/CEOGary ChristiansonChief Operating Officer
Diana HausmanChief Medical OfficerScott PetersonChief Scientific Officer
More Company Profile & Key Executives for 3O6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil